Kangmei Pharma | 600518 - Cash And Equivalent



Kangmei Pharma reported CNY894.14M in Cash and Equivalent for its fiscal quarter ending in March of 2025.


Cash And Equivalent Change Date
Alaunos Therapeutics USD 1.09M 592K Dec/2024
Avita Medical AUD 14.05M 3.4M Dec/2024
Cspc Pharmaceutical 6.78B 1.6B Dec/2024
Dianthus Therapeutics USD 13.24M 9.56M Jun/2025
Genomma Lab Internacional MXN 2.52B 358.52M Jun/2025
Hypermarcas BRL 1.2B 536.49M Jun/2025
Ionis Pharmaceuticals USD 297.3M 33.11M Jun/2025
IQVIA Holdings USD 2.04B 299M Jun/2025
Jiangsu Hengrui CNY 36.12B 12.04B Jun/2025
Kangmei Pharma CNY 894.14M 120.63M Mar/2025
Moderna USD 1.28B 344M Jun/2025
Organon & Co USD 599M 52M Jun/2025
Revvity USD 991.85M 145.77M Jun/2025
Sh Fosun Pharma CNY 12.96B 757.22M Jun/2025
Tectonic Therapeutic USD 287.38M 146.14M Jun/2025
Viatris USD 566.4M 188.6M Jun/2025
Wuxi Apptec CNY 21.49B 3.37B Jun/2025
Xeris Pharmaceuticals USD 59.28M 12.34M Jun/2025
Zz Pientze Pharmaceu 1.39B 93.82M Mar/2025